The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy

Am J Hematol. 2021 May 1;96(5):E171-E175. doi: 10.1002/ajh.26146. Epub 2021 Mar 24.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alleles
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow / pathology
  • Clone Cells
  • Gain of Function Mutation*
  • Genes, ras*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Induction Chemotherapy*
  • Kaplan-Meier Estimate
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Middle Aged
  • Mutation*
  • Prognosis
  • Progression-Free Survival
  • Proto-Oncogene Proteins p21(ras) / genetics
  • Recurrence
  • Remission Induction
  • Signal Transduction / genetics

Substances

  • Proto-Oncogene Proteins p21(ras)